European Society for Medical Oncology
As of TAT 2005, each congress in this series has been designated official ESMO Partnership Meeting. The European Society for Medical Oncology (ESMO) is the leading European professional organization committed to advancing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care.
ESMO's mission is to advance cancer care and cure through fostering and disseminating good science that leads to better medicine and determines best practice. In this way ESMO fulfils its goal to support oncology professionals in providing people with cancer with the most effective treatments available and the high-quality care they deserve.
The ESMO community is a powerful alliance of more than 7,000 committed oncology professionals from over 120 countries. As a trusted organization with 35 years of experience and over 500 expert officers, ESMO serves its members and the oncology community through: excellence in post-graduate oncology education and training; leadership in transforming evidence-based research into standards of cancer care in Europe; dedicated efforts to foster a more favorable environment for scientific research; innovative international platforms to share expertise, best practices and disseminate the most up-to-date scientific research to as wide an audience as possible.
ESMO's scientific journal, Annals of Oncology, ranks among the top clinical oncology journals worldwide. ESMO events are the meeting place in Europe for medical oncologists to update their knowledge, to network and to exchange ideas.
Join the myESMO community today! Please visit www.esmo.org to learn more.
National Cancer Institute / Center for Cancer Research
Since TAT 2008, the U.S. National Cancer Institute (NCI) / Center for Cancer Reseach (CCR) has been a co-sponsor of annual TAT congresses. NCI, authorized by the U.S. Congress in 1937 in the National Cancer Act, is one of 27 Institutes and Centers that make up the National Institutes of Health (NIH). NCI is the world's largest organization dedicated solely to cancer research, with a staff of almost 5,000 principal investigators and an annual budget of about 5 billion US dollars. NCI is responsible for conducting, fostering, and funding cancer research, as evidenced by the major advances generated through its intramural and extramural research programs.
NCI’s Center for Cancer Research (CCR) is home to more than 250 principal investigators and nearly 1,000 postdoctoral and clinical fellows working in intramural research. Its mission is to inform and empower the entire cancer research community by making breakthrough discoveries in basic and clinical cancer research and by developing these discoveries into new therapeutic interventions for adults and children afflicted with cancer or infected with HIV. CCR investigators collaborate with scientists at other NIH Institutes and Centers, as well as with extramural scientists in academia and industry, both in the U.S. and abroad.